The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
c-Met abnormatities in patients with genitourinary (GU) malignancies and outcomes with c-MET inhibitors.
Denis Leonardo Fontes Jardim
No relevant relationships to disclose
Debora De Melo Gagliato
No relevant relationships to disclose
Gerald Steven Falchook
Research Funding - EMD Serono
Jennifer J. Wheler
No relevant relationships to disclose
Ralph Zinner
No relevant relationships to disclose
Filip Janku
No relevant relationships to disclose
Vivek Subbiah
No relevant relationships to disclose
Sarina Anne Piha-Paul
No relevant relationships to disclose
Siqing Fu
No relevant relationships to disclose
Nizar M. Tannir
No relevant relationships to disclose
Paul Gettys Corn
No relevant relationships to disclose
Chad Tang
No relevant relationships to disclose
Kenneth R. Hess
No relevant relationships to disclose
Sinchita Roy-Chowdhuri
No relevant relationships to disclose
Razelle Kurzrock
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose
David S. Hong
Research Funding - Amgen